GlassScriptPhysician profile
Barry Sundland
NPI 1164599585
$2,296.84
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $425 · 2021: $746 · 2022: $286.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.67 | 2021-2022 | |
| Amgen INC. | $283.06 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $213.15 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $177.98 | 2019-2022 | |
| Allergan, INC. | $165.04 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.81 | 2020-2022 | |
| Glaxosmithkline, LLC. | $111.86 | 2019-2022 | |
| Eisai INC. | $110.98 | 2020 | |
| Novo Nordisk INC | $110.49 | 2019-2021 | |
| Pfizer INC. | $107.37 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $103.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $84.40 | 2019-2020 | |
| Lilly USA, LLC | $74.10 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $46.16 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.80 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $27.38 | 2021 | |
| Vanda Pharmaceuticals INC. | $23.40 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.44 | 2022 | |
| Seqirus USA INC | $19.80 | 2019 | |
| Nestle Healthcare Nutrition INC. | $19.49 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.16 | 2021 | |
| Horizon Therapeutics Plc | $16.89 | 2019 | |
| Astellas Pharma US INC | $12.57 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Sundland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.